ERRATUM|
March 2, 2023
Citation
Blood. 2022;140(19).. Blood 2023; 141 (9): 1094. doi: https://doi.org/10.1182/blood.2022019233
Download citation file:
Blood. 2022;140(19).. Blood 2023; 141 (9): 1094. doi: https://doi.org/10.1182/blood.2022019233
Download citation file:
On the cover of the 10 November 2022 issue (volume 140, issue 19), “Phase 1 trial of pyruvate kinase inhibitor mitapivat in sickle cell disease” should read “Phase 1 trial of pyruvate kinase activator mitapivat in sickle cell disease.”
Advertisement intended for health care professionals
Advertisement intended for health care professionals
Advertisement intended for health care professionals
Advertisement intended for health care professionals